Home › Cancro ovarico › Distretto di Columbia › Washington
Studi clinici su Cancro ovarico a Washington, DC
23 studi su Cancro ovarico cercano partecipanti presso sedi a Washington e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
The Vanguard Study: Testing a New Way to Screen for Cancer
In reclutamentoVolontari sani benvenuti
- Walter Reed National Military Medical Center, Bethesda · a 7 mi di distanza
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
In reclutamentoFase 2
- Walter Reed National Military Medical Center, Bethesda · a 7 mi di distanza
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
In reclutamentoFase 1
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
In reclutamentoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
In reclutamentoFase 1
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
In reclutamentoFase 2
- Holy Cross Hospital /ID# 275872, Silver Spring · a 7 mi di distanza
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
In reclutamentoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
In reclutamentoFase 3
- MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
In reclutamentoFase 1
- Georgetown University Medical Center, Washington D.C.
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
In reclutamentoFase 3
- Holy Cross Hospital, Silver Spring · a 7 mi di distanza
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
In reclutamentoFase 2
- Medstar Georgetown University Hospital, Washington D.C.
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
In reclutamentoFase 3
- Holy Cross Hospital, Silver Spring · a 7 mi di distanza
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
In reclutamentoFase 1/2
- Children's National Medical Center, Washington D.C.
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
In reclutamentoFase 1
- Normunity Investigational Site, Washington D.C.
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
In reclutamentoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
In reclutamentoFase 2
- USA11-0, Bethesda · a 7 mi di distanza
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
In reclutamentoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Cancer Support Community Research & Training Institute, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Silver Spring · a 7 mi di distanza
- Massive Bio SYNERGY-AI site, Bethesda · a 7 mi di distanza
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
In reclutamentoVolontari sani benvenuti
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
In reclutamentoFase 1
- Holy Cross Hospital, Silver Spring · a 7 mi di distanza
Studi su Cancro ovarico in altre città
- Houston, TX89 studi
- New York City, NY69 studi
- Boston, MA61 studi
- Los Angeles, CA50 studi
- Nashville, TN49 studi
- Arlington, VA46 studi
- Philadelphia, PA44 studi
- Columbus, OH39 studi
- St. Louis, MO38 studi
- Chicago, IL36 studi
- San Antonio, TX31 studi
- Cleveland, OH30 studi
Altri studi a Washington
- Cancro (tutti i tipi)58 studi
- Cancro del polmone non a piccole cellule55 studi
- Cancro al seno46 studi
- Cancro metastatico43 studi
- Cancro ai polmoni41 studi
- Cancro alla prostata38 studi
- Obesità33 studi
- Cancro colorettale29 studi
- Malattie cardiovascolari28 studi
- Cancro della vescica26 studi
- Leucemia mieloide acuta24 studi
- Linfoma23 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.